Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term adjuvant therapy. Found 22 abstracts

no pagination
Ristau BT, Manola J, Haas NB, Heng DY, Messing EM, Wood CG, Kane CJ, DiPaola RS, Uzzo RG. Retroperitoneal Lymphadenectomy in High-Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial. J Urol. 2018 Jan;199(1):53-9.   PMCID: PMC5800986
Gore JL, du Plessis M, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher Test Impacts Decision Making Among Patients Considering Adjuvant and Salvage Treatment After Radical Prostatectomy: Interim Results From the Multicenter Prospective PRO-IMPACT Study. Cancer. 2017 Aug;123(15):2850-9.   PMCID: PMC5573983
Gore JL, Plessis MD, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study. Cancer. 2017 Apr 19;.
Colt DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. Melanoma. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):366-400.   PMCID: not NIH funded
Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE. Mucosal Melanoma of the Head and Neck. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):320-38.   PMCID: not NIH Funded
Carlson RW, Allred C, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R. Invasive Breast Cancer. Journal of the National Comprehensive Cancer Network. 2011 Feb;9(2):136-222.   PMCID: not NIH funded - practice guideline
Ray ME, Bae K, Hussain MH, Hanks GE, Shipley WU, Sandler HM. Potential Surrogate Endpoints for Prostate Cancer Survival: Analysis of a Phase III Randomized Trial. Journal of the National Cancer Institute. 2009 Feb;101(4):228-36.   PMCID: PMC2734115
Svahn TH, Niland JC, Carlson RW, Hughes ME, Ottesen RA, Theriault RL, Edge SB, Schott AF, Bookman MA, Weeks JC. Predictors and Temporal Trends of Adjuvant Aromatase Inhibitor Use in Breast Cancer. Journal of the National Comprehensive Cancer Network. 2009 Feb;7(2):115-21.   PMCID: No NIH
Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. International Journal of Radiation Oncology Biology Physics. 2008 Jun;71(2):428-34.
Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Apr;295(14):1658-67.
Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg DF, Pollack A. What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?. International Journal of Radiation Oncology Biology Physics. 2005 Mar 15;61(4):1003-10.
Smith BL, Kopans DB, Koerner FC, Morrow M, Davidson NE, Partridge AH, Harris NL. Case 35-2005: A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node - Invasive ductal carcinoma of the breast with isolated tumor cells in a sentinel lymph node (T1b pN0 (i+)). New England Journal of Medicine. 2005 Nov 17;353(20):2177-85.
Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. The oncologist. 2004 Jan;9 (6):606-16.
Bruner DW, Boyd CP. Assessing women's sexuality after cancer therapy: Checking assumptions with the focus group technique. Cancer nursing. 1999 Dec;22(6):438-47.
Coia LR, Gunderson LL, Haller D, Hoffman J, Mohiuddin M, Tepper JE, Berkey B, Owen JB, Hanks GE. Outcomes of patients receiving radiation for carcinoma of the rectum - Results of the 1988-1989 patterns of care study. Cancer. 1999 Nov 15;86(10):1952-8.
Schilder RJ, Johnson S, Gallo J, Kindsfather S, Rogers B, Bookman MA, Millenson MM, Boente M, Rosenblum N, Litwin S, Ozols RF. Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells. Journal of Clinical Oncology. 1999 Jul;17(7):2198-207.
Minsky BD, Coia L, Haller D, Hoffman J, John M, Landry J, Pisansky TM, Willett C, Mahon I, Owen J, Hanks G. Treatment systems guidelines for primary rectal cancer from the 1996 patterns of care study. International Journal of Radiation Oncology Biology Physics. 1998 Apr;41(1):21-7.
Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM. Optimal Management of Malignant Mesothelioma after Subtotal Pleurectomy - Revisiting the Role of Intrapleural Chemotherapy and Postoperative Radiation. Journal of surgical oncology. 1995 Oct;60(2):100-5.
Sigurdson ER. Surgical palliation of colorectal cancer. Current Problems in Cancer. 1995 Nov;19(6):348-59.
Fowler WC, Langer CJ, Curran WJ, Keller SM. Postoperative Complications after Combined Neoadjuvant Treatment of Lung-Cancer. Annals of Thoracic Surgery. 1993 Apr;55(4):986-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term adjuvant therapy

adjuvant therapy chemotherapy cancer NCCN Clinical Practice Guidelines metastases NCCN Guidelines radiation biopsy randomized-trial radiation-therapy pathology postoperative radiotherapy radiotherapy quality of life combination overall survival malignant-melanoma follow-up survival breast-cancer mastectomy prostatectomy radical prostatectomy Decipher salvage therapy endocrine therapy recurrence melanoma breast cancer radiation therapy surgery decisional conflict prostate cancer postmenopausal women tamoxifen therapy postoperative postoperative radiation kit mutation tamoxifen bone-marrow transplantation Anxiety phase-iii randomized trial Neoplasm Metastasis clinical trials colony-stimulating factor biochemical failure resectability local excision placebo-controlled trial clinical-trial Male Aromatase inhibitors psychology stage-iii lymph node dissection pleural prostatic neoplasms IMPACT BONY LANDMARKS therapy oncology group Patterns of Care Study pulmonary-edema MALIGNANCIES 1987 arlson me-journal of chronic diseases-v40-p373 united-states intensity-modulated radiotherapy colon predict pathological stage three-dimensional conformal radiotherapy recursive partitioning analysis predictive factors surgical adjuvant recombinant interleukin-2 therapy breast neoplasms curative resection phase-iii trial ovarian-cancer anastrozole adenocarcinoma Conflict (Psychology) Surveys and Questionnaires 1993 n jkl-journal of dermatologic surgery and oncology-v19-p985 gleason score failure activator inhibitor type-1 prophylactic oophorectomy metastatic dose-response skin ADJUVANT TREATMENT Middle Aged intensive therapy colorectal-carcinoma sexuality surgical adjuvant breast Multivariate Analysis head and neck cancer prognostic factors IRRADIATION positron-emission-tomography comorbidity index colon-cancer quality-of-life isolated limb perfusion large-bowel-cancer sentinel-node biopsy ACUTE HEMATOLOGIC TOXICITY Salvage Therapy stage-iii melanoma rectal-carcinoma Prostatectomy metaanalysis lymph-node metastases Prostatic Neoplasms General & Internal Medicine c-erbb-2 expression pelvic therapy Prospective Studies lobular carcinoma in situ focus groups cell-carcinoma interferon sentinel lymph node skin-sparing mastectomy lymphadenectomy locally advanced-carcinoma growth-factor receptor CARCINOMA diffuse cooperative-oncology-group conformal radiation-therapy primary cutaneous melanoma RADIATION-THERAPY nonsentinel axillary nodes mucosal melanoma mesothelioma cutaneous group protocol 92-02 resectable adenocarcinoma cervical cancer adjuvant treatment expression oncology-technology-assessment margin external-beam radiotherapy gynecologic-oncology-group neck dissection resection
Last updated on Friday, August 14, 2020